:

Homeland Security

Emergent BioSolutions Acquires VaxGen’s Anthrax Vaccine Technology

DDN

Wednesday, May 14th, 2008

SHARE:

Emergent BioSolutions [EBS] has acquired the assets and rights to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. [VXGN] for $2 million plus a potential additional $8 million in milestone payments. The arrangement also includes specified percentages of future net sales. VaxGen's original $877 million contract to develop and produce a next-generation anthrax vaccine was terminated by the Department of Health and Human Services in December 2006 due to stability issues with the…

Congress

With $1.5 Trillion Request, Army, Air Force, Navy’s Unfunded Lists Focus Solely On MILCON Projects

With the Trump administration’s push to massively increase defense spending to $1.5 trillion in fiscal year 2027, the Army, Air Force and Navy have eschewed submitting large unfunded priorities lists […]

Unmanned Systems

Bipartisan House Bill Would Give National Guard To Counter-Drone Authorities

Seeking to close gaps that may arise between state and local law enforcers in different jurisdictions, a bipartisan contingent of House members this week introduced a bill that would allow […]

Congress

Munitions Fired Represent Most of $25 Billion Spent By Pentagon on Iran War So Far

Munitions fired in the two-month old “Operation Epic Fury” against Iran represent most of the $25 billion cost the Pentagon has incurred thus far in the conflict, the acting Defense […]

Congress

Slotkin: Pentagon Should Use Anthropic’s Mythos To Spot Cyber Security Gaps

The Pentagon should be using Anthropic‘s recently announced Mythos artificial intelligence model to spot gaps in cyber security, Sen. Elissa Slotkin (D-Mich.) said on Tuesda. “I think the thing that […]